Price $9.15 |
Market Cap
170.3M
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
-
|
P/B
1.41
|
P/S
0.48
|
Dividend %
4.40%
|
|
P/CF
11.6
|
P/FCF
11.2
|
Op. Cash Flow
20.6K
|
FCF
0.8
|
|
Op. Margin
0.70%
|
Net Margin
-4.00%
|
ROE
-11.50%
|
ROI
-11.70%
|
|
ROA
-7.10%
|
EPS Growth
-
|
Current Ratio
1.9
|
Debt/Equity
11.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Procyon Corp (PCYN) | $0.23 | - | - | 2M | Strong Buy |
| ImmuCell Corporation (ICCC) | $7.46 | - | - | 37.6M | Strong Buy |
| Cardinal Health Inc (CAH) | $52.60 | - | 3.70% | 16.15B | Strong Buy |
| Imprimis Pharmaceuticals Inc (IMMY) | $2.74 | - | - | 65.5M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $3.51 | - | - | 32M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
